A retrospective study of breast cancer subtypes: the risk of relapse and the relations with treatments (Q42492946)

1 November 2017

title

A retrospective study of breast cancer subtypes: the risk of relapse and the relations with treatments (English)

1 reference

1 November 2017

Yahong Wang

1

1 reference

1 November 2017

Quangui Yin

2

1 reference

1 November 2017

Qi Yu

3

1 reference

1 November 2017

Jing Zhang

4

1 reference

1 November 2017

Ziyu Liu

5

1 reference

1 November 2017

Shuling Wang

6

1 reference

1 November 2017

Shuhua Lv

7

1 reference

1 November 2017

Yun Niu

8

1 reference

1 November 2017

language of work or name

English

0 references

publication date

12 August 2011

1 reference

Breast Cancer Research and Treatment

1 November 2017

published in

1 reference

1 November 2017

volume

130

1 reference

1 November 2017

issue

2

1 reference

1 November 2017

page(s)

489-498

1 reference

Pathology characteristics that optimize outcome prediction of a breast screening trial

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1709-6

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1709-6

The molecular portraits of breast tumors are conserved across microarray platforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1709-6

Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1709-6

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1709-6

Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1709-6

Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1709-6

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1709-6

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1709-6

Conservation of breast cancer molecular subtypes and transcriptional patterns of tumor progression across distinct ethnic populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1709-6

Molecular classification of breast carcinomas by immunohistochemical analysis: are we ready?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1709-6

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1709-6

The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1709-6

Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1709-6

Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1709-6

Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1709-6

Breast cancer subtypes and the risk of local and regional relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1709-6

Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1709-6

Proliferation marker Ki-67 in early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1709-6

Minimal and small size invasive breast cancer with no axillary lymph node involvement: the need for tailored adjuvant therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1709-6

Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1709-6

Breast cancer molecular subclassification and estrogen receptor expression to predict efficacy of adjuvant anthracyclines-based chemotherapy: a biomarker study from two randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1709-6

Heterogeneity of breast cancer and implications of adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1709-6

Supervised risk predictor of breast cancer based on intrinsic subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1709-6

Sixteen-kinase gene expression identifies luminal breast cancers with poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1709-6

Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1709-6

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1709-6

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1709-6

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1709-6

Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1709-6

10.1007/S10549-011-1709-6

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

1 November 2017

1015046911

0 references

1 reference